For the Inventor, By the Inventor

Enter assignee name

Parsippany, NJ, United States of America

Interpace Diagnostics Corporation

USPTO Granted Patents = 10

CIPO Patents = 2

EPO Patents = 2

Trademarks = 19

Forward Citations = 4

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Sydney David Finkelstein (6 out of 7 patents)

Sara Ann Jackson (5 out of 5 patents)

Eric Matthew Gayle Ellsworth (5 out of 5 patents)

4. Dennis Morgan Smith, Jr (4 out of 4 patents)

5. Brendan Corcoran (3 out of 3 patents)

6. Sylvie Beaudenon-Huibregtse (2 out of 4 patents)

7. Ashish Choudhary (2 out of 4 patents)

8. Bernard Andruss (2 out of 2 patents)

9. Alex Adai (2 out of 4 patents)

10. Stephan Albrecht Hahn (2 out of 2 patents)

11. Jamie Michelle Bleicher (2 out of 2 patents)

12. Patricia Swalsky (1 out of 1 patent)

13. Anna Szafranska-Schwarzbach (1 out of 1 patent)

14. Anna Szafransak-Schwarzbach (1 out of 1 patent)

15. Dennis Morgan Smith (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 12205676 - Methods for treating Barrett's metaplasia and esophageal adenocarcinoma (2025-01-21),

2. 11143657 - Topographic genotyping for determining the diagnosis, malignant potential, and biologic behavior of pancreatic cysts and related conditions (2021-10-12),

3. 11118231 - miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms (2021-09-14),

4. 10655184 - Methods and compositions involving miR-135b for distinguishing pancreatic cancer from benign pancreatic disease (2020-05-19),

5. 10444239 - Methods for measuring carcinoembryonic antigen (2019-10-15),

6. 10255410 - Methods for treating Barrett's metaplasia and esophageal adenocarcinoma (2019-04-09),

7. 10150999 - miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms (2018-12-11),

8. 10131942 - Methods for treating barrett's metaplasia and esophageal adenocarcinoma (2018-11-20),

9. 9644241 - Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease (2017-05-09),

10. 9341628 - Methods for measuring carcinoembryonic antigen (2016-05-17),

Interpace Diagnostics Corporation is a healthcare company that provides molecular diagnostic tests, bioinformatics, and pathology services to help physicians make more accurate decisions for their patients. The company focuses on developing and commercializing diagnostic tests for thyroid, pancreatic, and other gastrointestinal cancers. Interpace Diagnostics aims to improve patient outcomes through innovative technology and personalized medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#41 in Parsippany, NJ

#1,101 in New Jersey

#29,002 in US

#54,308 in the World

Parsippany, NJ, United States of America

Interpace Diagnostics Corporation

Forward Citations = 4

15 inventors:

Sydney David Finkelstein (6 out of 7 patents)

Sara Ann Jackson (5 out of 5 patents)

Eric Matthew Gayle Ellsworth (5 out of 5 patents)

4. Dennis Morgan Smith, Jr (4 out of 4 patents)

5. Brendan Corcoran (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…